Jerusalem’s Hadassah Hospital is cautiously optimistic after the world’s first passive immunization of a critically ill coronavirus patient. After an injection of Kamada’s IgG antibody product , a CT-scan of the lungs showed some improvement and doctors are hopeful of a recovery.
A 3-year study by Hebrew University of Jerusalem scientists has discovered that a combination of an antiviral AIDS treatment and another to treat memory loss was effective in fighting liver and skin cancers. Separately, the medicines had no effect on the cancer.
Israel’s Holon Institute of Technology (HIT) is launching in October a new bachelor’s degree program in Medical Technology (Medtech). The first 60 students will study digital medical technologies, including telemedicine, smart medical systems, and big data.
This video highlights the enlightened approach and up-to-date facilities for psychiatric care at Mayanei Hayeshua Medical Center in Bnei Brak. Also, during the Covid-19 epidemic, the hospital successfully adopted tele-psychiatry – the new norm for patient-practitioner meetings.
A team from Bar-Ilan University was one of four winners of The Michael J. Fox Foundation for Parkinson’s Research DREAM Challenge. The Israelis were the only non-US winners from the 43 competing teams. Their winning entry focuses on movement disorders resulting from cell damage.
Doctors at Jerusalem’s Hadassah hospital used a nano-engineered supplement made from high antioxidant pomegranate oil to treat 30 multiple sclerosis patients. In just 3 months, the patients already significantly improved their learning ability, text comprehension, word recall and categorization.
The Coronavirus Data Challenge by Israel’s Sheba Medical Center was reported previously. It was won by Intel’s Analytics AI group’s system to predict patients with life-threatening reactions or needing ventilators. It will be implemented at Sheba and at Mount Sinai in New York.
In Covid-19 and autoimmune diseases, the body’s immune system goes out of control. Israeli biotech Stero uses CBD to reduce and even replace the usual steroid treatment for these diseases. With funding from Israel’s Clalit, it is trialing CBD on 30 Crohn’s steroid-dependent patients.
The original glucose monitor of Israel’s DarioHealth (reported previously) is now MyDario - a full Remote Patient Monitoring (RPM) device. DarioHealth has just been approved by the Centers for Medicare & Medicaid Services (CMS).
Internationally-conducted tests on the facemasks produced by Israel’s Sonovia (reported previously) have proved that the metal-oxide coated masks destroy the novel coronavirus. Sonovia produces several thousand masks per day and has sold several hundreds of thousands.